Market Cap 326.97M
Revenue (ttm) 0.00
Net Income (ttm) -80.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,549,100
Avg Vol 2,858,024
Day's Range N/A - N/A
Shares Out 82.78M
Stochastic %K 52%
Beta 1.00
Analysts Strong Sell
Price Target $16.70

Company Profile

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Industry: Biotechnology
Sector: Healthcare
Phone: 844 511 9056
Address:
Three Bala Plaza East, Suite 506, Bala Cynwyd, United States
agamemnus
agamemnus Oct. 25 at 12:15 AM
$LRMR this will start going above $5 and above $6 in the next few months imo.
0 · Reply
Chartist0_0
Chartist0_0 Oct. 24 at 10:43 PM
$LRMR forming a bull flag. No break out yet. Volume has been declining. Next week might be a pullback week. I think we want to be buyers on weakness.
0 · Reply
BioResearcher
BioResearcher Oct. 24 at 7:18 PM
$LRMR So, if approved, this will be a block-buster drug with revenue far exceed $ one billion !
1 · Reply
BioResearcher
BioResearcher Oct. 24 at 7:16 PM
$LRMR LRMR 's drug will likely be priced from $ 800K - one mil per year. IMHO. Look at other rare disease like DMD drugs, it costs about $700 - one mil a year. but FA is more rare than DMD, and LRMR's drug is treating the root of FA, most DMD drugs just treat some symptoms of DMD. In US, there are about 5,000 FA patients while DMD has about 15,000 patients. The price of the drug is proportional to the rare-ness of the disease. An example: this is recently approved drug for DMD:
0 · Reply
BioResearcher
BioResearcher Oct. 24 at 6:50 PM
$LRMR FA is a devastating disease. Similar to DMD. LRMR's drug is the only hope that FA patients like Sarah has. There are no approved drugs to treat the root cause of FA. I believe FDA will give it green light soon to help patients like Sarah.
0 · Reply
BioResearcher
BioResearcher Oct. 24 at 2:17 PM
$LRMR Glad I added below $ 4 last couple days. The data show this drug is so effective that it is almost like a cure for FA. I don't think FDA would deny it due to some FA patients have Anaphylaxis because that would deny the majority of FA patients a chance to live. They have shown Anaphylaxis is manageable if it happens.
1 · Reply
dump4sho
dump4sho Oct. 23 at 12:49 AM
$LRMR is this gonna be low in Feb too ?
0 · Reply
Chartist0_0
Chartist0_0 Oct. 22 at 4:43 PM
$LRMR get ready
3 · Reply
Ab3000
Ab3000 Oct. 22 at 4:37 PM
0 · Reply
BioResearcher
BioResearcher Oct. 21 at 8:42 PM
$LRMR This is a vote of confidence: Huge insider bought 2 months ago, They are the ones who know their drug inside out. They interacts with FDA so they know that FDA thinks about this drug.
0 · Reply
Latest News on LRMR
Larimar Therapeutics, Inc. - Special Call

Sep 29, 2025, 2:47 PM EDT - 25 days ago

Larimar Therapeutics, Inc. - Special Call


What's Going On With Larimar Therapeutics Stock On Tuesday?

Dec 17, 2024, 1:39 PM EST - 11 months ago

What's Going On With Larimar Therapeutics Stock On Tuesday?


Why Is Larimar Therapeutics Stock Trading Lower On Monday?

Dec 16, 2024, 12:17 PM EST - 11 months ago

Why Is Larimar Therapeutics Stock Trading Lower On Monday?


Larimar: Friedreich's Ataxia Drug With Significant Potential

Aug 2, 2023, 6:02 AM EDT - 2 years ago

Larimar: Friedreich's Ataxia Drug With Significant Potential


Larimar Therapeutics Set to Join Russell 3000® Index

Jun 21, 2023, 4:05 PM EDT - 2 years ago

Larimar Therapeutics Set to Join Russell 3000® Index


agamemnus
agamemnus Oct. 25 at 12:15 AM
$LRMR this will start going above $5 and above $6 in the next few months imo.
0 · Reply
Chartist0_0
Chartist0_0 Oct. 24 at 10:43 PM
$LRMR forming a bull flag. No break out yet. Volume has been declining. Next week might be a pullback week. I think we want to be buyers on weakness.
0 · Reply
BioResearcher
BioResearcher Oct. 24 at 7:18 PM
$LRMR So, if approved, this will be a block-buster drug with revenue far exceed $ one billion !
1 · Reply
BioResearcher
BioResearcher Oct. 24 at 7:16 PM
$LRMR LRMR 's drug will likely be priced from $ 800K - one mil per year. IMHO. Look at other rare disease like DMD drugs, it costs about $700 - one mil a year. but FA is more rare than DMD, and LRMR's drug is treating the root of FA, most DMD drugs just treat some symptoms of DMD. In US, there are about 5,000 FA patients while DMD has about 15,000 patients. The price of the drug is proportional to the rare-ness of the disease. An example: this is recently approved drug for DMD:
0 · Reply
BioResearcher
BioResearcher Oct. 24 at 6:50 PM
$LRMR FA is a devastating disease. Similar to DMD. LRMR's drug is the only hope that FA patients like Sarah has. There are no approved drugs to treat the root cause of FA. I believe FDA will give it green light soon to help patients like Sarah.
0 · Reply
BioResearcher
BioResearcher Oct. 24 at 2:17 PM
$LRMR Glad I added below $ 4 last couple days. The data show this drug is so effective that it is almost like a cure for FA. I don't think FDA would deny it due to some FA patients have Anaphylaxis because that would deny the majority of FA patients a chance to live. They have shown Anaphylaxis is manageable if it happens.
1 · Reply
dump4sho
dump4sho Oct. 23 at 12:49 AM
$LRMR is this gonna be low in Feb too ?
0 · Reply
Chartist0_0
Chartist0_0 Oct. 22 at 4:43 PM
$LRMR get ready
3 · Reply
Ab3000
Ab3000 Oct. 22 at 4:37 PM
0 · Reply
BioResearcher
BioResearcher Oct. 21 at 8:42 PM
$LRMR This is a vote of confidence: Huge insider bought 2 months ago, They are the ones who know their drug inside out. They interacts with FDA so they know that FDA thinks about this drug.
0 · Reply
BioResearcher
BioResearcher Oct. 21 at 3:06 PM
$LRMR If approved, this drug can generate > $1.X billion it is the only one drug can treat the root cause of FA. DMD drugs costing $700 K - $ 1 mil per year. LRMR can easily be priced above $700 K... IMHO
0 · Reply
BioResearcher
BioResearcher Oct. 21 at 1:16 PM
$LRMR This drug treats the root cause of FA, so it can treat both mobility and heart failure issues in FA patients. Heart failure is the leading cause of death in FA. The only approved drug is Skyclarys, and it only slowly down the loss of mobility. LRMR's drug can save life, FDA knows the benefits so they have been working with management to mitigate the Anaphylaxis issue.
0 · Reply
alexpitti
alexpitti Oct. 20 at 11:38 PM
I met with ceo and cfo of $LRMR today
1 · Reply
BioResearcher
BioResearcher Oct. 20 at 8:18 PM
$LRMR This drug can save life, Anaphylaxis caused by this drug is mild and can be treated. The newly released data shows efficacy is a slam dunk. This drug is like the DMD drug Elevidys, it address the root cause of the disease instead of treating just the symptoms. Elevidys has killed some patients, but FDA just give black box label to Elevidys, but it is still on the market because it is vital to the DMD patients. The worse case is Nomlabofusp gets black-box label when it is approved. IMHO.
0 · Reply
PremarketAnalysis
PremarketAnalysis Oct. 19 at 1:36 AM
$LRMR SignalEngine: MM Infl (Bullish) (1h bias), Algo Vol 62%, Org Vol 38%, Res 4.53, Sup 3.88 Algo Int: Spoofing detected.. tape managed to absorb retail flow before broader move. Momentum Feed: https://premarketanalysis.com/#momentum=LRMR
0 · Reply
Chartist0_0
Chartist0_0 Oct. 18 at 1:00 AM
$LRMR 3.60$ coming over the next couple weeks. Buy dip for move to almost 12$.
0 · Reply
Ab3000
Ab3000 Oct. 17 at 3:12 PM
0 · Reply
DeadPresidentsTrader
DeadPresidentsTrader Oct. 16 at 5:15 PM
$LRMR Check out @DeadPresidentsTrader message on Stocktwits http://stocktwits.com/DeadPresidentsTrader/message/632610855
0 · Reply
Chartist0_0
Chartist0_0 Oct. 16 at 4:36 PM
$LRMR keep powder dry. Next two weeks gonna be rough for markets
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Oct. 16 at 2:27 PM
$LRMR https://www.tipranks.com/news/company-announcements/larimar-therapeutics-reports-promising-clinical-data-update
0 · Reply
Ab3000
Ab3000 Oct. 16 at 1:49 PM
$LRMR Praise be to God !
1 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Oct. 15 at 11:19 PM
0 · Reply